Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1

Conditions

Sarcoma 85Lymphoma 58Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Non-Hodgkin 34Osteosarcoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Hodgkin Disease 25Burkitt Lymphoma 24Testicular Neoplasms 22Neuroectodermal Tumors, Primitive, Peripheral 19Ovarian Neoplasms 18Leukemia 18Lymphoma, Follicular 17Fibrosarcoma 16Testicular Germ Cell Tumor 15Neuroblastoma 15Teratoma 14Rhabdomyosarcoma 14Lymphoma, Large-Cell, Immunoblastic 14Liposarcoma 14Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Anaplastic 13Hemangiosarcoma 13Recurrence 12Neurofibrosarcoma 12Leiomyosarcoma 12Histiocytoma, Malignant Fibrous 12Central Nervous System Neoplasms 12Sarcoma, Synovial 11Lymphoma, B-Cell, Marginal Zone 11

Interventions

Mitomycin 3Hyperthermic Intraperitoneal Chemotherapy 3Surveys and Questionnaires 2Oxaliplatin 2Leucovorin 2Fluorouracil 2Capecitabine 2Bromelains 2Acetylcysteine 2tislelizumab 1molgramostim 1irinotecan sucrosofate 1cryoprecipitate coagulum 1Tacrolimus 1Standard of Care 1Specimen Handling 1Sirolimus 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Observation 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Lansoprazole 1Ipilimumab 1Ifosfamide 1Gemcitabine 1Floxuridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Ifosfamide × Clear all
NCT03034850 2017-01-27

Thrombin Generation and Platelet Activation in CRS/HIPEC

Ziekenhuis Oost-Limburg

Completed
27 enrolled
GynecologicOther solid neoplasmThoracic

Mesothelioma, Peritoneal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡